Deep Track Capital is an investment firm exclusively focused on the life sciences industry, particularly biotechnology and healthcare. The firm's strategy involves forming long-term partnerships with public and pre-IPO companies, providing capital, strategic guidance, and leveraging their network through a fundamentally driven, research-intensive approach.
Portfolio
1
Fund Size
$5.1B
Top Stage
Series C
Last 12 Mo
1
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
| Attovia Therapeutics | Series C | $90M | Apr 2025 |
Top Co-Investors
Sanofi Ventures1 shared
Goldman Sachs Alternatives1 shared
Cormorant Asset Management1 shared
Marshall Wace1 shared
Last updated: 27 February 2026